| Efficacy and Safety of Valsartan/Amlodipine Compared to Amlodipine in Patients With Essential Hypertension (NCT00437645) | Novartis Pharmaceuticals | 2007-01-01 |
| Study of Oral LBH589 in Adult Patients With Refractory Cutaneous T-Cell Lymphoma (NCT00425555) | Novartis Pharmaceuticals | 2007-01-01 |
| Efficacy and Safety of AEB071 Versus Tacrolimus in Combination With Mycophenolate Acid Sodium, Basiliximab and Steroids in Preventing Acute Rejection After Kidney Transplantation (NCT00492869) | Novartis Pharmaceuticals | 2007-01-01 |
| Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers (NCT00432068) | Novartis Pharmaceuticals | 2007-01-01 |
| A Phase I/II Study of BEZ235 in Patients With Advanced Solid Malignancies Enriched by Patients With Advanced Breast Cancer (NCT00620594) | Novartis Pharmaceuticals | 2006-12-21 |
| Combination Of Lapatinib With Carboplatin, Paclitaxel, and With or Without Trastuzumab In Metastatic Breast Cancer. (NCT00367471) | Novartis Pharmaceuticals | 2006-12-07 |
| Efficacy, Safety and Tolerability of Everolimus in Preventing End-stage Renal Disease in Patients With Autosomal Dominant Polycystic Kidney Disease (NCT00414440) | Novartis Pharmaceuticals | 2006-12-01 |
| Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or Intolerant (NCT00413270) | Novartis Pharmaceuticals | 2006-12-01 |
| Efficacy, Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail (NCT00443898) | Novartis Pharmaceuticals | 2006-12-01 |
| Everolimus and Octreotide in Patients With Advanced Carcinoid Tumor (NCT00412061) | Novartis Pharmaceuticals | 2006-12-01 |
| Safety of Everolimus and Pemetrexed in Lung Cancer Patients (NCT00434174) | Novartis Pharmaceuticals | 2006-12-01 |
| Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B (NCT00412529) | Novartis Pharmaceuticals | 2006-12-01 |
| Long Term Efficacy and Safety of Zoledronic Acid Treatment in Patients With Bone Metastases (NCT00434447) | Novartis Pharmaceuticals | 2006-12-01 |
| Efficacy Safety, and Tolerability of Topical Terbinafine in Patients With Mild to Moderate Toenail Fungus of the Big Toenail (NCT00443820) | Novartis Pharmaceuticals | 2006-12-01 |
| Safety/Efficacy of Valsartan/Hydrochlorothiazide Combination Compared to Hydrochlorothiazide in Obese Hypertensive Adults (NCT00439738) | Novartis Pharmaceuticals | 2006-12-01 |
| Effect of Omalizumab on Expression of IgE Receptors in Adults With Severe, Inadequately Controlled Allergic Asthma (NCT00454051) | Novartis Pharmaceuticals | 2006-12-01 |
| Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis (NCT00439647) | Novartis Pharmaceuticals | 2006-12-01 |
| Efficacy and Safety of Everolimus in Patients With Metastatic Colorectal Cancer Who Have Failed Prior Targeted Therapy and Chemotherapy (NCT00419159) | Novartis Pharmaceuticals | 2006-12-01 |
| Measurement of Patient Reported Outcomes in Korean Renal Transplant Patients With and Without Gastrointestinal (GI) Symptoms (NCT00529269) | Novartis Pharmaceuticals | 2006-12-01 |
| Evaluate the Effects of Patupilone on the Pharmacokinetics of Midazolam and Omeprazole in Patients With Advanced Malignancies (NCT00420615) | Novartis Pharmaceuticals | 2006-12-01 |
| Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing's Disease (NCT00434148) | Novartis Pharmaceuticals | 2006-12-01 |
| Impact of Hepatic Impairment on the Pharmacokinetics of Deferasirox. (NCT00432627) | Novartis Pharmaceuticals | 2006-12-01 |
| Patients Completing Core Protocol (CAMN107A2103), Exhibiting Stable Disease (SD), Partial Response (PR) or Complete Response (CR) to Nilotinib in Combination With Imatinib (NCT00441155) | Novartis Pharmaceuticals | 2006-11-01 |
| The Effects of Systolic Blood Pressure Lowering on Diastolic Function Using Valsartan + Amlodipine in Patients With Hypertension and Diastolic Dysfunction (NCT00523549) | Novartis Pharmaceuticals | 2006-11-01 |
| Efficacy and Safety of Valsartan and Amlodipine in Patients With Essential Hypertension (NCT00425373) | Novartis Pharmaceuticals | 2006-11-01 |
| Safety and Efficacy of Nateglinide in Patients With Type 2 Diabetes Already Taking Insulin Glargine, Metformin and/or Pioglitazone or Rosiglitazone (NCT00402909) | Novartis Pharmaceuticals | 2006-11-01 |
| Dose Ranging Study for Indacaterol in Japanese Asthma Patients (NCT00403754) | Novartis Pharmaceuticals | 2006-11-01 |
| Pharmacokinetics of Nilotinib in Subjects With Impaired Hepatic Function and Healthy Subjects With Normal Hepatic Function (NCT00418626) | Novartis Pharmaceuticals | 2006-11-01 |
| RAD001 Plus Best Supportive Care (BSC) Versus BSC Plus Placebo in Patients With Metastatic Carcinoma of the Kidney Which Has Progressed After Treatment With Sorafenib and/or Sunitinib (NCT00410124) | Novartis Pharmaceuticals | 2006-11-01 |
| Study of Zoledronic Acid Administered Monthly Versus Every 3 Months in Multiple Myeloma and Breast Cancer Patients Who Were Treated With Zoledronic Acid the Prior Year (NCT00424983) | Novartis Pharmaceuticals | 2006-11-01 |
| Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP) (NCT00428909) | Novartis Pharmaceuticals | 2006-11-01 |
| Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects. (NCT00416442) | Novartis Pharmaceuticals | 2006-10-01 |
| Enteric-coated Mycophenolate Sodium (EC-MPS) and Mycophenolate Mofetil (MMF) in Renal Transplant Patients With Gastrointestinal (GI) Intolerance (NCT00400400) | Novartis Pharmaceuticals | 2006-10-01 |
| Efficacy and Safety of AEB071 Plus Tacrolimus (Converted to Mycophenolic Acid After 3 Months), in Renal Transplant Patients (NCT00403416) | Novartis Pharmaceuticals | 2006-10-01 |
| Effects of Rifampin on the Pharmacokinetics of Nilotinib in Healthy Subjects (NCT00418756) | Novartis Pharmaceuticals | 2006-10-01 |
| Treatment of Patients With Everolimus and Imatinib Mesylate Who Have Progressive Gastro Intestinal Stromal Tumors (GIST) and Are Resistant to Imatinib Mesylate (NCT00510354) | Novartis Pharmaceuticals | 2006-10-01 |
| Efficacy/Safety of Vildagliptin and Metformin Combination Therapy in Patients With Type 2 Diabetes Not Well Controlled With Metformin Alone (NCT00396357) | Novartis Pharmaceuticals | 2006-10-01 |
| Safety and Efficacy of Vildagliptin vs. Thiazolidinedione as add-on Therapy to Metformin in Patients With Type 2 Diabetes Not Controlled With Metformin Alone (NCT00396227) | Novartis Pharmaceuticals | 2006-10-01 |
| Efficacy and Safety of Everolimus in Combination With Cyclosporine Microemulsion Versus Everolimus in Combination With Enteric-coated Mycophenolate Sodium (EC-MPS), in Adult Renal Transplant Patients in Maintenance. (NCT00425308) | Novartis Pharmaceuticals | 2006-10-01 |
| Efficacy and Safety of Vildagliptin Compared to Placebo on the Incretin Effect in Patients With Type 2 Diabetes Treated With Metformin (NCT00396071) | Novartis Pharmaceuticals | 2006-10-01 |
| Feasibility and Safety of Early Switch to Everolimus From Cyclosporine in de Novo Renal Transplant Patients (NCT00464399) | Novartis Pharmaceuticals | 2006-09-01 |
| Efficacy of Fixed Combination Therapy of Vildagliptin and Metformin Compared to the Individual Monotherapy Components in Drug Naive Patients With Type 2 Diabetes (NCT00382096) | Novartis Pharmaceuticals | 2006-09-01 |
| Efficacy and Safety of Patupilone in Men (≥18 Years) With Metastatic Hormone Refractory Prostate Cancer (NCT00411528) | Novartis Pharmaceuticals | 2006-09-01 |
| A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly (NCT00368277) | Novartis Pharmaceuticals | 2006-09-01 |
| Efficacy and Safety of Vildagliptin Compared to Metformin in Elderly Drug Naive Patients With Type 2 Diabetes (NCT00383578) | Novartis Pharmaceuticals | 2006-09-01 |
| Effect of APL180 on Endothelial Function in Familial Hypercholesterolemia Patients (NCT00751608) | Novartis Pharmaceuticals | 2006-09-01 |
| Study to Evaluate the Efficacy and Safety of Sandostatin LAR at High Dose or in Combination Either With GH-receptor Antagonist or Dopamine-agonist in Acromegalic Patients (NCT01278342) | Novartis Pharmaceuticals | 2006-09-01 |
| Pharmacokinetics of Patupilone After a Single Intravenous Administration in Patients With Advance Solid Tumor Malignancies. (NCT00426140) | Novartis Pharmaceuticals | 2006-08-01 |
| Combination Trial of Patupilone and Carboplatin in Adult Patients With Advanced Solid Tumors (NCT00426582) | Novartis Pharmaceuticals | 2006-08-01 |
| Safety and Efficacy of Deferasirox (ICL670) in Patients With Iron Overload Resulting From Hereditary Hemochromatosis (NCT00395629) | Novartis Pharmaceuticals | 2006-08-01 |
| Efficacy and Safety of Patupilone in Patients With Advanced Solid Tumors in Japan (NCT00412789) | Novartis Pharmaceuticals | 2006-08-01 |
| Efficacy and Safety of Mycograb as Adjunctive Therapy for Cryptococcal Meningitis in Patients With AIDS (NCT00847678) | Novartis Pharmaceuticals | 2006-08-01 |
| Preservation of Renal Function in Liver Transplant Recipients With Certican Therapy (NCT00378014) | Novartis Pharmaceuticals | 2006-08-01 |
| Study To Assess Long Term Safety Of Pazopanib (NCT00387205) | Novartis Pharmaceuticals | 2006-06-20 |
| Intensified vs. Standard Dose Therapy With Mycophenolate Sodium Plus Cyclosporin Microemulsion and Corticosteroid Combination in Patients With de Novo Renal Transplant Patients (NCT00369278) | Novartis Pharmaceuticals | 2006-06-01 |
| Effect of Food on Bioavailability of a Modified Release Formulation of Imatinib (NCT00422825) | Novartis Pharmaceuticals | 2006-06-01 |
| Efficacy and Safety of Letrozole vs. Letrozole Plus Zoledronic Acid as Endocrine Therapy Before Surgery in Postmenopausal Patients With Breast Cancer (NCT00375752) | Novartis Pharmaceuticals | 2006-06-01 |
| Safety/Efficacy of Everolimus in Adults With Advanced Pancreatic Neuroendocrine Cancer Not Responsive to Chemotherapy (NCT00363051) | Novartis Pharmaceuticals | 2006-06-01 |
| Study of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly and Patients With Carcinoid Disease (NCT00446082) | Novartis Pharmaceuticals | 2006-06-01 |
| Bioavailability Study Comparing Two New Nilotinib Tablet Formulations to an Established Nilotinib Capsule Formulation in Healthy Volunteers (NCT00418769) | Novartis Pharmaceuticals | 2006-06-01 |
| EXTEND (Eltrombopag Extended Dosing Study) (NCT00351468) | Novartis Pharmaceuticals | 2006-06-01 |
| A Dose Escalation of Gimatecan Administered Orally to Japanese Patients With Advanced Solid Tumor. (NCT00410358) | Novartis Pharmaceuticals | 2006-06-01 |
| Efficacy and Safety of Imatinib and Vinorelbine in Patients With Advanced Breast Cancer (NCT00372476) | Novartis Pharmaceuticals | 2006-06-01 |
| Gastrointestinal and Health-related Quality of Life Outcomes in Patients With Autoimmune Diseases Treated With Mycophenolate (NCT00351377) | Novartis Pharmaceuticals | 2006-06-01 |
| Safety and Efficacy Study of Femara(Letrozole) as an Extended Adjuvant Treatment in Breast Cancer Patients (NCT01249456) | Novartis Pharmaceuticals | 2006-05-01 |
| Imatinib Mesylate Treatment of Patients With Malignant Peripheral Nerve Sheath Tumors (NCT00427583) | Novartis Pharmaceuticals | 2006-05-01 |
| A Study to Evaluate the Efficiency of Intravenously Administered Cyclosporine in de Novo Liver Transplant Recipients (NCT00332462) | Novartis Pharmaceuticals | 2006-05-01 |
| Adjuvant Docetaxel-Zoledronic Acid in High-risk Early Prostate Cancer Following Prostatectomy. (NCT00258765) | Novartis Pharmaceuticals | 2006-05-01 |
| Efficacy of Vildagliptin 100 MG as Compared to Placebo as Add-on to Metformin in Patients With Type 2 Diabetes (NCT00351884) | Novartis Pharmaceuticals | 2006-05-01 |
| A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function (NCT00421044) | Novartis Pharmaceuticals | 2006-05-01 |
| Effect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast Cancer (NCT00334139) | Novartis Pharmaceuticals | 2006-05-01 |
| Safety of LBH589 Alone and in Combination With Intravenous Docetaxel and Prednisone (NCT00419536) | Novartis Pharmaceuticals | 2006-05-01 |
| Safety of LBH589 Alone and in Combination With IV Docetaxel and Prednisone (NCT00493766) | Novartis Pharmaceuticals | 2006-05-01 |
| Everolimus in Combination With Cyclosporine Microemulsion in de Novo Renal Transplant Recipients (NCT01276457) | Novartis Pharmaceuticals | 2006-05-01 |
| Efficacy and Safety of Oral AMN107 in Adults With Chronic Myelogenous Leukemia Resistant and/or Intolerant to Imatinib Mesylate Therapy (NCT00264160) | Novartis Pharmaceuticals | 2006-05-01 |
| Efficacy and Safety of Cyclosporine A Microemulsion in Maintenance Patients With Chronic Plaque Psoriasis (NCT00438360) | Novartis Pharmaceuticals | 2006-05-01 |
| Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients (NCT00537862) | Novartis Pharmaceuticals | 2006-05-01 |
| Safety of TKI258 in Advanced/Metastatic Melanoma Subjects (NCT00303251) | Novartis Pharmaceuticals | 2006-04-01 |
| A Study to Evaluate RAF265, an Oral Drug Administered to Subjects With Locally Advanced or Metastatic Melanoma (NCT00304525) | Novartis Pharmaceuticals | 2006-04-01 |
| Efficacy and Safety of Daptomycin Versus Vancomycin or Teicoplanin for Treatment of Complicated Skin and Soft Tissue Infections (NCT00430937) | Novartis Pharmaceuticals | 2006-04-01 |
| Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension (NCT00477269) | Novartis Pharmaceuticals | 2006-04-01 |
| A Study of Zoledronic Acid in the Prevention of Cancer Therapy-induced Bone Loss (NCT00333229) | Novartis Pharmaceuticals | 2006-03-01 |
| Dose-escalation Study of Gimatecan Administered in Two Different Schedules in Adult Patients With Advanced Solid Tumors (NCT00420485) | Novartis Pharmaceuticals | 2006-03-01 |
| SOCRATES: Steroid or Cyclosporine Removal After Transplantation Using Everolimus (NCT00371826) | Novartis Pharmaceuticals | 2006-03-01 |
| Letrozole as Early Adjuvant Treatment of Postmenopausal Patients With Primary Breast Cancer (NCT00332852) | Novartis Pharmaceuticals | 2006-03-01 |
| Efficacy and Safety of Famciclovir 1-day Treatment Compared to 3-day Treatment With Valacyclovir in Adults With Recurrent Genital Herpes (NCT00306787) | Novartis Pharmaceuticals | 2006-03-01 |
| Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly (NCT00376064) | Novartis Pharmaceuticals | 2006-03-01 |
| Efficacy of Lumiracoxib in Relieving Moderate to Severe Post-dental Surgery Pain, Compared to Both Placebo and Celecoxib (NCT00348491) | Novartis Pharmaceuticals | 2006-02-01 |
| Safety of Tobramycin Inhalation Powder (TIP) vs Tobramycin Solution for Inhalation in Patients With Cystic Fibrosis (NCT00388505) | Novartis Pharmaceuticals | 2006-02-01 |
| Safety and Efficacy of Hormone Therapy With Letrozole in Postmenopausal Women With Breast Cancer (NCT00330317) | Novartis Pharmaceuticals | 2006-02-01 |
| Continued Efficacy and Safety of Zoledronic Acid (q 4 Wks vs. q 12 Wks) in the 2nd Year of Treatment in Patients With Bone Metastases From Breast Cancer (NCT00320710) | Novartis Pharmaceuticals | 2006-02-01 |
| Efficacy/ Safety of Omalizumab in Patients With Seasonal Allergic Asthma and Seasonal Allergic Rhinoconjunctivitis (NCT00396409) | Novartis Pharmaceuticals | 2006-02-01 |
| Efficacy and Safety of Low-molecular Weight Heparin for Thromboprophylaxis in Acutely Ill Medical Patients (NCT00311753) | Novartis Pharmaceuticals | 2006-02-01 |
| Safety and Efficacy of Zoledronic Acid in Patients With Breast Cancer With Metastatic Bone Lesions (NCT00375427) | Novartis Pharmaceuticals | 2006-02-01 |
| Study In Women And Men With Metastatic Breast Cancer That Have Overexpression Of ErbB2 (NCT00281658) | Novartis Pharmaceuticals | 2006-01-02 |
| Liver Fibrosis in Patients Transplanted for Hepatitis C Receiving Either Cyclosporine Microemulsion or Tacrolimus (NCT00260208) | Novartis Pharmaceuticals | 2006-01-01 |
| A Study of Patupilone in Patients With Advanced Solid Tumors and Varying Degrees of Hepatic Function (NCT00420524) | Novartis Pharmaceuticals | 2006-01-01 |
| Patupilone Activity in Advanced/Metastatic Hepatocellular Carcinoma (NCT00273312) | Novartis Pharmaceuticals | 2006-01-01 |
| Efficacy and Safety of Everolimus in Recipients of Heart Transplants to Prevent Acute and Chronic Rejection (NCT00300274) | Novartis Pharmaceuticals | 2006-01-01 |
| Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia (NCT00302016) | Novartis Pharmaceuticals | 2006-01-01 |